Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Name: Liquidia Corp: Is Infosys Ltd. worth buying?
Item: Liquidia Corp
Rating: 2.508791625
Author: Trendlyne DVM scores

Expensive Rocket

about

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

56.97 0.04 (0.07%)

New 52W High in past week

1.4M

XNAS Volume

XNAS 18 May, 2026 5:30 PM (EDT)

Board Meeting

The board meeting for Liquidia Corp is scheduled for today, for the purpose of H.C. Wainwright 4(th) Annual Bioconnect Investor Conference at NASDAQ See details

Medium Financial Strength

50.0 / 100

Expensive Valuation

22.8 / 100

Technically Bullish

77.9 / 100

Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM

1Yr Price target upside is 14%

8 analysts

Liquidia Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

New 52W High in past week

SWOT Analysis

Liquidia Corp Live Price Chart